Wealth Enhancement Advisory Services’s LeMaitre Vascular LMAT Stock Holding History

Wealth Enhancement Advisory Services’s Portfolio LMAT Stock Details LMAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$369K	Buy	3,587 +510	+17%	+$52.3K	﹤0.01%	2996
2026 Q1	$334K	Sell	3,077 -952	-24%	-$90.7K	﹤0.01%	2672
2025 Q4	$336K	Sell	4,029 -107	-3%	-$9.21K	﹤0.01%	2823
2025 Q3	$359K	Sell	4,136 -9	-0.2%	-$804	﹤0.01%	2636
2025 Q2	$350K	Sell	4,145 -67	-2%	-$5.6K	﹤0.01%	2512
2025 Q1	$353K	Sell	4,212 -494	-10%	-$46K	﹤0.01%	2317
2024 Q4	$434K	Sell	4,706 -53	-1%	-$5.1K	﹤0.01%	2097
2024 Q3	$442K	Sell	4,759 -19	-0.4%	-$1.65K	﹤0.01%	1901
2024 Q2	$393K	Sell	4,778 -775	-14%	-$56.9K	﹤0.01%	1799
2024 Q1	$369K	Sell	5,553 -113	-2%	-$6.97K	﹤0.01%	1777
2023 Q4	$322K	Buy	5,666 +51	+0.9%	+$2.67K	﹤0.01%	1764
2023 Q3	$306K	Buy	+5,615	New	+$333K	﹤0.01%	1730

Other funds holding LMAT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

CCM

Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Wealth Enhancement Advisory Services's LMAT Position: Q2 2026 in Review

Wealth Enhancement Advisory Services increased its LeMaitre Vascular (LMAT) stake by 17% in Q2 2026, buying an estimated $52.3K and bringing the position to 3,587 shares worth $369K. The position accounts for ﹤0.01% of the portfolio, ranked #2996.

Wealth Enhancement Advisory Services first reported a position in LMAT in Q3 2023 and has held it in 12 quarters since. The position peaked at $442K in Q3 2024. 326 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.

Wealth Enhancement Advisory Services held 3,587 shares of LeMaitre Vascular worth $369K as of Q2 2026.
Wealth Enhancement Advisory Services bought 510 LeMaitre Vascular shares in Q2 2026, an estimated $52.3K.
LeMaitre Vascular made up ﹤0.01% of Wealth Enhancement Advisory Services's portfolio in Q2 2026, its #2996 holding.
Wealth Enhancement Advisory Services first reported a position in LeMaitre Vascular in Q3 2023 and has held it in 12 quarters since.
Wealth Enhancement Advisory Services's LeMaitre Vascular position peaked at $442K in Q3 2024.
326 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.

Based on Wealth Enhancement Advisory Services's 13F filing for Q2 2026, filed 15 Jul 2026.